Application of the Latest Immuno-Oncology Developments to the Treatment of Urothelial Cancer

Download All
Review insights from top experts in Europe and South America on new and established treatment strategies leveraging immune checkpoint inhibitors for care of patients with urothelial carcinoma with this Podcast series, on-demand Webcast, and downloadable slides.
person default
Georgios Gakis, MD
Petros Grivas, MD, PhD
Marine Gross-Goupil, MD, PhD
Félix Guerrero Ramos, MD, PhD, FEBU
person default
Mario Wolfgang Kramer, MD, PhD
person default
Alejandro Nolazco, MD
person default
José Ignacio Nolazco, MD
person default
Thomas Powles, MBBS, MRCP, MD
person default
Giuseppe Procopio, MD
Alain Ravaud, MD, PhD
person default
Óscar Rodríguez-Faba, MD
Jonathan E. Rosenberg, MD
Cora N. Sternberg, MD, FACP
Michiel van der Heijden, MD, PhD

Downloadable PDFs

Experts from France provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma.

Marine Gross-Goupil, MD, PhD Alain Ravaud, MD, PhD Released: December 9, 2020

Experts from the Netherlands and the United Kingdom provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma

person default Thomas Powles, MBBS, MRCP, MD Michiel van der Heijden, MD, PhD Released: December 10, 2020

Experts from Argentina provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma.

person default Alejandro Nolazco, MD person default José Ignacio Nolazco, MD Released: March 1, 2021

Experts from Argentina provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma.

person default Alejandro Nolazco, MD person default José Ignacio Nolazco, MD Released: March 1, 2021

Experts from Italy provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma.

person default Giuseppe Procopio, MD Cora N. Sternberg, MD, FACP Released: March 1, 2021

Experts from Italy provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma.

person default Giuseppe Procopio, MD Cora N. Sternberg, MD, FACP Released: March 1, 2021

Experts from Spain provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma

Félix Guerrero Ramos, MD, PhD, FEBU person default Óscar Rodríguez-Faba, MD Released: March 11, 2021

Experts from Spain provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma.

Félix Guerrero Ramos, MD, PhD, FEBU person default Óscar Rodríguez-Faba, MD Released: March 11, 2021

Experts from the USA provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma.

Petros Grivas, MD, PhD Jonathan E. Rosenberg, MD Released: March 19, 2021

Experts from Germany provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma.

person default Georgios Gakis, MD person default Mario Wolfgang Kramer, MD, PhD Released: May 21, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue